OPTIMIZATION OF TREATMENT METHODS FOR ALVEOLITIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Read full text Summarise with VIRAT
Authors: Shahzoda Samadova
Cited by: 0
References: 6

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Alveolitis represents an inflammatory condition of the pulmonary alveoli that can lead to impaired gas exchange and progressive respiratory dysfunction. In patients with type 2 diabetes mellitus (T2DM), chronic hyperglycemia, immune dysregulation, and microvascular complications contribute to altered inflammatory responses and delayed tissue repair, potentially worsening the course of alveolar inflammatory diseases. This article provides a narrative review of the pathophysiological interactions between alveolitis and T2DM and discusses strategies for optimizing treatment in this high-risk population. Evidence suggests that comprehensive management, including strict glycemic control, anti inflammatory therapy, careful use of corticosteroids, antimicrobial protection when indicated, and pulmonary rehabilitation, can improve outcomes. The paper highlights the importance of an individualized, multidisciplinary approach to managing alveolitis in patients with T2DM.

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Asthma and respiratory diseases Pneumonia and Respiratory Infections

Publication details

Journal / source
Экономика и социум
Publication date
1 January 2026
Language
EN